U.S. Physical Therapy (USPH) Fundamental Analysis: Revenue, Earnings & Valuation

8.87 / 10

Outperform

Fundamentally, USPH scores 8.87/10, rated Outperform. Strong Asset‑MV and Revenue‑MV relative to market boost its rating, while total profit growth is solid. However, cash‑flow metrics and earnings‑per‑share growth are negative, tempering the otherwise robust profile.

Analysis Checks(4/10)

Revenue-MV

Value0.21

Score3/3

Weight47.32%

1M Return7.98%

Net cash flow from operating activities per share (YoY growth rate %)

Value-0.03

Score0/3

Weight-12.31%

1M Return-3.08%

PB-ROE

Value-0.08

Score1/3

Weight-1.84%

1M Return-0.34%

Basic earnings per share (YoY growth rate %)

Value-22.83

Score2/3

Weight8.62%

1M Return1.70%

Total profit (YoY growth rate %)

Value29.24

Score1/3

Weight7.47%

1M Return1.41%

Net cash flow from operating activities (YoY growth rate %)

Value0.16

Score0/3

Weight-12.04%

1M Return-2.92%

Cash-UP

Value-0.11

Score1/3

Weight3.40%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value-22.83

Score2/3

Weight6.30%

1M Return1.25%

Asset-MV

Value-0.55

Score3/3

Weight60.09%

1M Return9.13%

Cash-MV

Value-0.44

Score0/3

Weight-7.01%

1M Return-1.72%

Is USPH undervalued or overvalued?

USPH scores 8.87/10 on fundamentals and holds a Discounted valuation at present. Backed by its 5.18% ROE, 7.43% net margin, 28.56 P/E ratio, 1.47 P/B ratio, and -22.83% earnings growth, these metrics solidify its Outperform investment rating.